Literature DB >> 14734762

Overproduction of TNF-alpha by CD8+ type 1 cells and down-regulation of IFN-gamma production by CD4+ Th1 cells contribute to toxic shock-like syndrome in an animal model of fatal monocytotropic ehrlichiosis.

Nahed Ismail1, Lynn Soong, Jere W McBride, Gustavo Valbuena, Juan P Olano, Hui-Min Feng, David H Walker.   

Abstract

Human monocytotropic ehrlichiosis (HME) is an emerging, life-threatening, infectious disease caused by Ehrlichia chaffeensis, an obligate intracellular bacterium that lacks cell wall LPS. We have previously developed an animal model of severe HME using a strain of Ehrlichia isolated from Ixodes ovatus ticks (IOE). To understand the basis of susceptibility to severe monocytotropic ehrlichiosis, we compared low and high doses of the highly virulent IOE strain and the less virulent Ehrlichia muris strain that are closely related to E. chaffeensis in C57BL/6 mice. Lethal infections caused by high or low doses of IOE were accompanied by extensive liver damage, extremely elevated levels of TNF-alpha in the serum, high frequency of Ehrlichia-specific, TNF-alpha-producing CD8(+) T cells in the spleen, decreased Ehrlicha-specific CD4(+) T cell proliferation, low IL-12 levels in the spleen, and a 40-fold decrease in the number of IFN-gamma-producing CD4(+) Th1 cells. All groups contained negligible numbers of IL-4-producing cells in the spleen. Transfer of Ehrlichia-specific polyclonal Abs and IFN-gamma-producing Ehrlichia-specific CD4(+) and CD8(+) type 1 cells protected naive mice against lethal IOE challenge. Interestingly, infection with high dose E. muris provided protection against rechallenge with a lethal dose of IOE. Cross-protection was associated with substantial expansion of IFN-gamma-producing CD4(+) and CD8(+) cells, but not TNF-alpha-producing CD8(+) T cells, a high titer of IgG2a, and a low serum level of TNF-alpha. In conclusion, uncontrolled TNF-alpha production by CD8(+) T cells together with a weak CD4(+) Th1 cell response are associated with immunopathology and failure to clear IOE in the fatal model of HME.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734762     DOI: 10.4049/jimmunol.172.3.1786

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

Review 1.  Molecular and cellular pathobiology of Ehrlichia infection: targets for new therapeutics and immunomodulation strategies.

Authors:  Jere W McBride; David H Walker
Journal:  Expert Rev Mol Med       Date:  2011-01-31       Impact factor: 5.600

2.  T cell-dependent IgM memory B cells generated during bacterial infection are required for IgG responses to antigen challenge.

Authors:  Jennifer L Yates; Rachael Racine; Kevin M McBride; Gary M Winslow
Journal:  J Immunol       Date:  2013-06-26       Impact factor: 5.422

3.  Impaired germinal center responses and suppression of local IgG production during intracellular bacterial infection.

Authors:  Rachael Racine; Derek D Jones; Madhumouli Chatterjee; Maura McLaughlin; Katherine C Macnamara; Gary M Winslow
Journal:  J Immunol       Date:  2010-03-29       Impact factor: 5.422

4.  Ixodes ovatus Ehrlichia exhibits unique ultrastructural characteristics in mammalian endothelial and tick-derived cells.

Authors:  Ulrike G Munderloh; David J Silverman; Katherine C MacNamara; Gilbert G Ahlstrand; Madhumouli Chatterjee; Gary M Winslow
Journal:  Ann N Y Acad Sci       Date:  2009-05       Impact factor: 5.691

5.  Essential role for humoral immunity during Ehrlichia infection in immunocompetent mice.

Authors:  Eric Yager; Constantine Bitsaktsis; Bisweswar Nandi; Jere W McBride; Gary Winslow
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

6.  The interaction between IL-18 and IL-18 receptor limits the magnitude of protective immunity and enhances pathogenic responses following infection with intracellular bacteria.

Authors:  Purnima Ghose; Asim Q Ali; Rong Fang; Digna Forbes; Billy Ballard; Nahed Ismail
Journal:  J Immunol       Date:  2011-06-29       Impact factor: 5.422

7.  Type I interferon contributes to noncanonical inflammasome activation, mediates immunopathology, and impairs protective immunity during fatal infection with lipopolysaccharide-negative ehrlichiae.

Authors:  Qin Yang; Heather L Stevenson; Melanie J Scott; Nahed Ismail
Journal:  Am J Pathol       Date:  2014-12-04       Impact factor: 4.307

8.  Histologic, serologic, and molecular analysis of persistent ehrlichiosis in a murine model.

Authors:  Juan P Olano; Gary Wen; Hui-Min Feng; Jere W McBride; David H Walker
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

9.  Protective heterologous immunity against fatal ehrlichiosis and lack of protection following homologous challenge.

Authors:  Nagaraja R Thirumalapura; Heather L Stevenson; David H Walker; Nahed Ismail
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

10.  Antigenic protein modifications in Ehrlichia.

Authors:  S Thomas; N Thirumalapura; E C Crossley; N Ismail; D H Walker
Journal:  Parasite Immunol       Date:  2009-06       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.